Initial and maintenance dose of vitamin D2 in the treatment of anticonvulsant osteomalacia.
D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D001842:Bone and Bones / Q000032:analysis; D002118:Calcium / Q000097:blood; D004827:Epilepsy / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology; D004872:Ergocalciferols / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008903:Minerals / Q000032:analysis; D010018:Osteomalacia / Q000139:chemically induced / Q000188:drug therapy* / Q000517:prevention & control; D010672:Phenytoin / Q000009:adverse effects / Q000097:blood; D013997:Time Factors
D004872:Ergocalciferols; D008903:Minerals; D010672:Phenytoin; D000469:Alkaline Phosphatase; D002118:Calcium